Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-RAD LABORATORIES, INC. Director's Dealing 2015

Sep 15, 2015

30786_dirs_2015-09-14_cca1f739-7dc3-4d29-99db-bc44f636230f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO RAD LABORATORIES INC (BIO, BIOB)
CIK: 0000012208
Period of Report: 2015-09-10

Reporting Person: SCHWARTZ NORMAN D (Director, Chairman, President, and CEO, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-09-10 Bio-Rad B Common Stock M 2000 Acquired 195308 Direct
2015-09-10 Bio-Rad B Common Stock J 1058 Disposed 194250 Direct
2015-09-11 Bio-Rad A Common Stock S 1058 $137.3628 Disposed 411252 Direct
2015-09-11 Bio-Rad B Common Stock M 2600 Acquired 196850 Direct
2015-09-11 Bio-Rad B Common Stock J 1371 Disposed 195479 Direct
2015-09-14 Bio-Rad A Common Stock S 1371 $138.5006 Disposed 411252 Direct
2015-09-12 Bio-Rad B Common Stock M 2617 Acquired 198096 Direct
2015-09-12 Bio-Rad B Common Stock J 1380 Disposed 196716 Direct
2015-09-14 Bio-Rad A Common Stock S 1380 $138.4978 Disposed 411252 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-09-10 Restricted Stock Units $0 M 2000 Disposed Bio-Rad B Common Stock (2000) Direct
2015-09-11 Restricted Stock Units $0 A 16000 Acquired Bio-Rad B Common Stock (16000) Direct
2015-09-11 Non-Qualified Stock Option (right to buy) $139.56 A 16000 Acquired 2025-09-11 Bio-Rad B Common Stock (16000) Direct
2015-09-11 Restricted Stock Units $0 M 2600 Disposed Bio-Rad B Common Stock (2600) Direct
2015-09-12 Restricted Stock Units $0 M 2617 Disposed Bio-Rad B Common Stock (2617) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Bio-Rad B Common Stock 12486 Indirect
Bio-Rad B Common Stock 4060054 Indirect
Bio-Rad B Common Stock 13726 Indirect

Footnotes

F1: Shares of Class B common stock acquired on the vesting of restricted stock units.

F2: The reporting person elected to convert shares of Class B common stock into Class A common stock on a 1-for-1 basis.

F3: Sold by the issuer on behalf of the reporting person to satisfy certain tax obligations in connection with the vesting of restricted stock units, all in accordance with a restricted stock unit award agreement.

F4: The reporting person disclaims beneficial ownership of these shares.

F5: The shares are held by a limited partnership of which the reporting person is a limited and general partner. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

F6: The shares are held by a limited partnership of which the reporting person is a limited partner.

F7: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class B common stock.

F8: The restricted stock units vest in five equal annual installments beginning September 10, 2015.

F9: The restricted stock units vest over five years at 20% per year on the yearly anniversary date of the grant.

F10: The stock option vests over five years at 20% per year on the yearly anniversary date of the grant.

F11: The restricted stock units vest in five equal annual installments beginning September 11, 2014.

F12: The restricted stock units vest in five equal annual installments beginning September 12, 2013.